ABSTRACT. Capsaicin has effects on the adiposity by increasing energy and lipid metabolism, and decreases appetite and fat intake. In the present study, we investigated changes in food intake and body weight after capsaicin treatment. We also observed changes in orexigenic and anorexigenic neuropeptides-agouti-related peptide (AgRP), -melanocyte-stimulating hormone (-MSH), adrenocorticotropic hormone (ACTH) and orexin-immunoreactivities in the rat hypothalamus after capsaicin administration. Only one day after capsaicin treatment, the mean food intake was significantly decreased. There was no significant difference in the mean body weight between vehicle-and capsaicin-treated groups. In addition, after capsaicin treatment, numbers of AgRP-and orexin-immunoreactive ( + ) cells were significantly decreased in the arcuate nucleus (ARC) and lateral hypothalamic area, respectively. In contrast, the number of -MSH + and ACTH + cells in the ARC of the capsaicin-treated rats was higher than in the vehicle-treated rats. These results indicate that capsaicin reduces food intake, not body weight, transiently, and decreases AgRP and orexin immunoreactivities, whereas it increases -MSH and ACTH immunoreactivities in rat hypothalamic nuclei. Capsaicin is a major pungent ingredient present in a variety of capsicum fruits, such as red peppers [34]. Since its initial identification in 1919, numerous pharmacological effects of capsaicin have been investigated and reported [20,34,39]. It has been known that capsaicin reduces adiposity by increasing energy and lipid metabolism in rats and decreases appetite and fat intake in humans [15,39]. It was recently reported that the capsaicin receptor, vanilloid receptor subtype 1 (VR1), was found throughout the central nervous system, including the hypothalamic nuclei [19,33].Many researchers have focused on specific neuropeptides, neurotransmitters, receptors and neuronal circuits that both neuroanatomically and neurophysiologically control food intake in the central nervous system [4,31,32]. The hypothalamus is thought to be a major center for controlling feeding behavior in the brain [10]. In many hypothalamic nuclei, the arcuate nucleus (ARC) and the lateral hypothalamic area (LH) are regarded as important centers for regulating food intake and energy homeostasis [4,10]. In the hypothalamus, many neuropeptides, such as neuropeptide Y, orexin, agouti-related peptid and proopiomelanocortin, are known to participate in regulating food intake [10].Agouti-related peptide (AgRP) is expressed only in the ARC of the hypothalamus and that AgRP-containing neurons project to various hypothalamic nuclei, such as the paraventricular nucleus and LH [7]. AgRP is known to be a potent stimulant of food intake and to be involved in the maintenance of feeding behavior [37].On the other hand, it has been reported that AgRP is an endogenous antagonist of melanocortin receptor (subtype 4) (MC4-R), which functions to control food intake and energy homeostasis in the hypothalamus [9,12]. Proopiomelanocort...